It was reported in recent years that several genetic variations (such as COMT Val158Met[25], BDNF val66met[26], mu opioid receptor polymorphism and dopamine D2 receptor intronic dinucleotide repeat polymorphism[27]) were associated with the occurrence of motor complications, especially for dyskinesia. This evidence concerns the gene DRD2 and Dyskinesia.